Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

What was recalled

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Recalling firm: Eugia US LLC
NDC code: 55150-306-10
Origin: NJ, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0186-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Progesterone recalls

See all

Class II · Moderate risk Ongoing Apr 25, 2025

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US…

Reason Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified…

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0330-01 D-0400-2025

Class II · Moderate risk Ongoing Dec 18, 2024

medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US…

Reason CGMP Deviations

Eugia US LLC NDC 55150-329-01 D-0185-2025

Class II · Moderate risk Ongoing Jul 26, 2024